Nils Bergenhem

This profile gathers the share dealings of Nils Bergenhem in CPEX Pharmaceuticals, Inc. We count 3 filings, every one of them for a trade on 5 April 2011.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 7 April 2011, reports an option exercise in CPEX Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.